Právní předpis byl sestaven k datu 13.04.2026.
Zobrazené znění právního předpisu je účinné od 27.07.2013.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2014
195/2013 Sb.
195
SDĚLENÍ
Ministerstva zdravotnictví
ze xxx 3. července 2013
o xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx a mimořádná xxxxxxxx pro xxx 2014
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 odst. 1 xxxx. x) zákona x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx a o xxxxx některých xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx imunizační komise xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2014:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné obrně (xxxxxxxxxxxx forma), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx externae proteinum
Diphtheriae xxxxxxxxxx
Xxxxxx xxxxxxxxxx xxx.
Xxxxxxxxx xxxxxxxxx hepatitidis B xxxxxxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 3
Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx influenzae x, Xxxxxx xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulárni xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx anatoxinum
Haemagglutinum xxxxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (Xxxxxxx)
xxxxx 2 (XXX-1)
xxxxx 3 (Xxxxxxx)
Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X
Xxxxxxxxxxx xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phasphas)
conjugata xxx xxxxxx xxxxxxxxxx
1x) xxxxxxxx xxxxx proti záškrtu, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx (DTaP):
Diphtheriae xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx jednotek
Tetani xxxxxxxxxx ≥ 40 mezinárodních xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (PT) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69kD) 8 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx influenzae b (XXxXXxx):
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx
|
&xxxx;
xxx. 30 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxx anatoxinum
|
min. 40 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxx (XX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum (XXX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx (69xX)
|
&xxxx;
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx X
|
&xxxx;
10 mikrogramů
|
|
cum xxxxxxxxx tetanico
|
20-40 xxxxxxxxxx
|
1x) xxxxxxxx xxxxx proti xxxxxxx a xxxxxx - xxxxxxxxx:
Xxxxxxxxxx diphtheriae xxxxxxxxxxx ... xxx. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxxx xxxxxx xxxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) očkovací látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x:
1 xxxxx lyofilizované xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (30 mikrogramů).
1f) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx látka xxxxx virové hepatitidě X xx 15 xxx xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 10 xxxxxxxxxx
1x) očkovací xxxxx proti xxxxxx xxxxxxxxxx X xx 16 let a xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 20 xxxxxxxxxx
1xx) xxxxxxxx látka xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:
Morbillorum xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu50
Parotitidis xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50
1x) xxxxxxxx xxxxx xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Xxxxxxx) ... 40 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 2 (XXX-1) ... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 3 (Xxxxxxx) ... 32 xxxxxxxxxxx X jednotek*
* nebo xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx vhodné xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx xxxxx xxxxx nákazám xxxxxxxxx Xxxxxxxxxxxxx pneumoniae x polysacharidové xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx typus:
1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9X, 10X, 11X, 12F, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X ... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx
1x) xxxxxxxx látka xxxxxxxxxxx xxxxx pneumokokovým xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx polysaccharidum sérotypus 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 9X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 14
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 18X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) xxxxxxxx látka xxxxx záškrtu, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx
|
&xxxx;
xx xxxx xxx 2 mezinárodní jednotky
|
|
Tetani xxxxxxxxxx
|
&xxxx;
xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx
|
Xxxxxxxxx xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxxxxxx
|
&xxxx;
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
|
&xxxx;
8 mikrogramů
|
|
Pertaktin
|
2,5 xxxxxxxxxx
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
| &xxxx;
xxxxx 1 (kmen Xxxxxxx)
|
&xxxx;
40 X xxxxxxxx xxxxxxxx
|
| &xxxx;
xxxxx 2 (kmen MEF-1)
|
8 X jednotek xxxxxxxx
|
| &xxxx;
xxxxx 3 (xxxx Xxxxxxx)
|
&xxxx;
32 X jednotek xxxxxxxx
|
XXXX
1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma):
|
Difterický toxoid
|
více xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)
|
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
xxxx nebo xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Lf)
|
Pertusové xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
2,5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxx
|
&xxxx;
5 mikrogramů
|
|
Fimbrie xxxx 2+3
|
&xxxx;
5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
3 xxxxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx typu 1 (xxxxxxxxxxxx)
|
&xxxx;
40 xxxxxxxxxxx X xxxxxxxx
|
| &xxxx;
Xxxxx poliomyelitis typu 2 (xxxxxxxxxxxx)
|
&xxxx;
8 antigenních X jednotek
|
|
Virus xxxxxxxxxxxxx xxxx 3 (inaktivovaný)
|
32 xxxxxxxxxxx X xxxxxxxx
|
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:
Xxxxxxxx Xxxxxxxx Guérin (xxxxxxxxxx) 100&xxxx;000 - 300&xxxx;000 X.X.*
(xxxx Copenhagen 1331)
*X.X. = xxxx xxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro xxxxx xxxxxxxx xx dialyzačního xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) očkovací látka xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:
Antigenum xxxxxxxxx xxxxxxxxxxx B ... 20 mikrogramů
2b) xxxxxxxx látka xxxxx xxxxxxxxx
Xxxxx xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx XX/XX 38 1503-3M více xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 xxxxx (0,5 xx)
2x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx xxxxxxx:
Xxxxxxxxx A xxxxx inactivatum
3. Antigenní xxxxxxx xxxxxxxxxx xxxxx xxx mimořádná xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X virus xxxxxxxxxxx
3x) xxxxxxxx látka xxxxx virové hepatitidě X ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
Xxxxxxx:
xxx. XXXx. Xxxxx, XXx., x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 195/2013 Sb. xxxxx xxxxxxxxx dnem 27.7.2013.
Xx xxx xxxxxxxx xxxxxx xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.